Pre-clinical development of the human CD40 agonistic antibody ADC-1013

Documenti analoghi

• ADC-1013, an agonistic CD40 antibody optimized for local immunotherapy of cancer
  di: Mangsbo, Sara M, et al.
  Pubblicazione: (2013)
• The human CD40 agonistic antibody ADC-1013 generates immune mediated anti-tumor effects in syngeneic tumor models in hCD40 transgenic mice
  di: Mangsbo, Sara M, et al.
  Pubblicazione: (2014)
• Kick-starting the cancer-immunity cycle by targeting CD40
  di: Ellmark, P, et al.
  Pubblicazione: (2015)
• Tumor-directed immunotherapy can generate tumor-specific T cell responses through localized co-stimulation
  di: Ellmark, Peter, et al.
  Pubblicazione: (2016)
• Pre-assembly of the extracellular domains of CD40 is not necessary for rescue of mouse B cells from anti-immunoglobulin M-induced apoptosis
  di: Ellmark, Peter, et al.
  Pubblicazione: (2003)